The Expression Pattern of Small Nucleolar and Small Cajal Body-specific RNAs Characterizes Distinct Molecular Subtypes of Multiple Myeloma

Overview

Journal Blood Cancer J

Date 2012 Nov 27

PMID 23178508

Citations 48

Authors

D Ronchetti

K Todoerti

G Tuana

L Agnelli

L Mosca

M Lionetti

S Fabris

P Colapietro

M Miozzo

M Ferrarini

P Tassone

A Neri

Affiliations

Soon will be listed here.

Abstract

Small nucleolar RNAs (snoRNAs) and small Cajal body-specific RNAs (scaRNAs) are non-coding RNAs involved in the maturation of other RNA molecules and generally located in the introns of host genes. It is now emerging that altered sno/scaRNAs expression may have a pathological role in cancer. This study elucidates the patterns of sno/scaRNAs expression in multiple myeloma (MM) by profiling purified malignant plasma cells from 55 MMs, 8 secondary plasma cell leukemias (sPCLs) and 4 normal controls. Overall, a global sno/scaRNAs downregulation was found in MMs and, even more, in sPCLs compared with normal plasma cells. Whereas SCARNA22 resulted the only sno/scaRNA characterizing the translocation/cyclin D4 (TC4) MM, TC2 group displayed a distinct sno/scaRNA signature overexpressing members of SNORD115 and SNORD116 families located in a region finely regulated by an imprinting center at 15q11, which, however, resulted overall hypomethylated in MMs independently of the SNORD115 and SNORD116 expression levels. Finally, integrative analyses with available gene expression and genome-wide data revealed the occurrence of significant sno/scaRNAs/host genes co-expression and the putative influence of allelic imbalances on specific snoRNAs expression. Our data extend the current view of sno/scaRNAs deregulation in cancer and add novel information to the bio-molecular complexity of plasma cell dyscrasias.

Citing Articles

The dual role of circHIPK3 in cancer and its implications for multiple drugs resistance: a systematic review and computational approach.

Campelo M, Reis-das-Merces L, Vidal A, da Silva F, de Oliveira A, Monteiro J Front Oncol. 2025; 15:1547889.

PMID: 40061896 PMC: 11885226. DOI: 10.3389/fonc.2025.1547889.

Truncated variants of MAGEL2 are involved in the etiologies of the Schaaf-Yang and Prader-Willi syndromes.

Heimdorfer D, Vorleuter A, Eschlbock A, Spathopoulou A, Suarez-Cubero M, Farhan H Am J Hum Genet. 2024; 111(7):1383-1404.

PMID: 38908375 PMC: 11267527. DOI: 10.1016/j.ajhg.2024.05.023.

Small Cajal Body-Specific RNA12 Promotes Carcinogenesis through Modulating Extracellular Matrix Signaling in Bladder Cancer.

Lu Q, Wang J, Tao Y, Zhong J, Zhang Z, Feng C Cancers (Basel). 2024; 16(3).

PMID: 38339238 PMC: 10854576. DOI: 10.3390/cancers16030483.

Oncogene SCARNA12 as a potential diagnostic biomarker for colorectal cancer.

Zhang H, Liu X, Zhang W, Deng J, Lin C, Qi Z Mol Biomed. 2023; 4(1):37.

PMID: 37907779 PMC: 10618143. DOI: 10.1186/s43556-023-00147-x.

Decoding the 'Fifth' Nucleotide: Impact of RNA Pseudouridylation on Gene Expression and Human Disease.

Jalan A, Jayasree P, Karemore P, Narayan K, Khandelia P Mol Biotechnol. 2023; 66(7):1581-1598.

PMID: 37341888 DOI: 10.1007/s12033-023-00792-1.

References

Ceci M, Gaviraghi C, Gorrini C, Sala L, Offenhauser N, Marchisio P . Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly. Nature. 2003; 426(6966):579-84. DOI: 10.1038/nature02160. View

Irizarry R, Hobbs B, Collin F, Beazer-Barclay Y, Antonellis K, Scherf U . Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003; 4(2):249-64. DOI: 10.1093/biostatistics/4.2.249. View

Kishore S, Khanna A, Zhang Z, Hui J, Balwierz P, Stefan M . The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing. Hum Mol Genet. 2010; 19(7):1153-64. PMC: 2838533. DOI: 10.1093/hmg/ddp585. View

Pichiorri F, De Luca L, Aqeilan R . MicroRNAs: New Players in Multiple Myeloma. Front Genet. 2012; 2:22. PMC: 3268577. DOI: 10.3389/fgene.2011.00022. View

Runte M, Huttenhofer A, Gross S, Kiefmann M, Horsthemke B, Buiting K . The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. Hum Mol Genet. 2001; 10(23):2687-700. DOI: 10.1093/hmg/10.23.2687. View

Shaughnessy Jr J, Zhan F, Burington B, Huang Y, Colla S, Hanamura I . A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood. 2006; 109(6):2276-84. DOI: 10.1182/blood-2006-07-038430. View

Scott M, Ono M . From snoRNA to miRNA: Dual function regulatory non-coding RNAs. Biochimie. 2011; 93(11):1987-92. PMC: 3476530. DOI: 10.1016/j.biochi.2011.05.026. View

Chapman M, Lawrence M, Keats J, Cibulskis K, Sougnez C, Schinzel A . Initial genome sequencing and analysis of multiple myeloma. Nature. 2011; 471(7339):467-72. PMC: 3560292. DOI: 10.1038/nature09837. View

Mei Y, Liao J, Shen J, Yu L, Liu B, Liu L . Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene. 2011; 31(22):2794-804. PMC: 4966663. DOI: 10.1038/onc.2011.449. View

10.

Lopez-Corral L, Mateos M, Corchete L, Sarasquete M, Rubia J, de Arriba F . Genomic analysis of high-risk smoldering multiple myeloma. Haematologica. 2012; 97(9):1439-43. PMC: 3436247. DOI: 10.3324/haematol.2011.060780. View

11.

Morgan G, Walker B, Davies F . The genetic architecture of multiple myeloma. Nat Rev Cancer. 2012; 12(5):335-48. DOI: 10.1038/nrc3257. View

12.

Bazeley P, Shepelev V, Talebizadeh Z, Butler M, Fedorova L, Filatov V . snoTARGET shows that human orphan snoRNA targets locate close to alternative splice junctions. Gene. 2007; 408(1-2):172-9. PMC: 6800007. DOI: 10.1016/j.gene.2007.10.037. View

13.

Agnelli L, Fabris S, Bicciato S, Basso D, Baldini L, Morabito F . Upregulation of translational machinery and distinct genetic subgroups characterise hyperdiploidy in multiple myeloma. Br J Haematol. 2007; 136(4):565-73. DOI: 10.1111/j.1365-2141.2006.06467.x. View

14.

Ronchetti D, Lionetti M, Mosca L, Agnelli L, Andronache A, Fabris S . An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma. BMC Med Genomics. 2008; 1:37. PMC: 2531129. DOI: 10.1186/1755-8794-1-37. View

15.

Brameier M, Herwig A, Reinhardt R, Walter L, Gruber J . Human box C/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs. Nucleic Acids Res. 2010; 39(2):675-86. PMC: 3025573. DOI: 10.1093/nar/gkq776. View

16.

Gorski J, Pathak S, Panov K, Kasciukovic T, Panova T, Russell J . A novel TBP-associated factor of SL1 functions in RNA polymerase I transcription. EMBO J. 2007; 26(6):1560-8. PMC: 1829371. DOI: 10.1038/sj.emboj.7601601. View

17.

Valleron W, Laprevotte E, Gautier E, Quelen C, Demur C, Delabesse E . Specific small nucleolar RNA expression profiles in acute leukemia. Leukemia. 2012; 26(9):2052-60. DOI: 10.1038/leu.2012.111. View

18.

Fabris S, Ronchetti D, Agnelli L, Baldini L, Morabito F, Bicciato S . Transcriptional features of multiple myeloma patients with chromosome 1q gain. Leukemia. 2007; 21(5):1113-6. DOI: 10.1038/sj.leu.2404616. View

19.

Michel C, Holley C, Scruggs B, Sidhu R, Brookheart R, Listenberger L . Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. Cell Metab. 2011; 14(1):33-44. PMC: 3138526. DOI: 10.1016/j.cmet.2011.04.009. View

20.

Hideshima T, Bergsagel P, Kuehl W, Anderson K . Advances in biology of multiple myeloma: clinical applications. Blood. 2004; 104(3):607-18. DOI: 10.1182/blood-2004-01-0037. View